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Abstract
Multiple new approaches to tackle multidrug resistant infections are urgently needed and
under evaluation. One nanotechnology-based approach to delivering new relevant thera-
peutics involves silicon accumulator plants serving as a viable silicon source in green
routes for the fabrication of the nanoscale drug delivery carrier porous silicon (pSi). If the
selected plant leaf components contain medicinally-active species as well, then a single
substance can provide not only the nanoscale high surface area drug delivery carrier, but
the drug itself. With this idea in mind, porous silicon was fabricated from joints of the silicon
accumulator plant Bambuseae (Tabasheer) and loaded with an antibacterial extract origi-
nating from leaves of the same type of plant (Bambuseae arundinacea). Preparation of
porous silicon from Tabasheer includes extraction of biogenic silica from the ground plant
by calcination, followed by reduction with magnesium in the presence of sodium chloride,
thereby acting as a thermal moderator that helps to retain the mesoporous structure of the
feedstock. The purified product was characterized by a combination of scanning electron
microscopy (SEM), energy dispersive X-ray analysis (EDX), X-ray diffraction (XRD),
Raman spectroscopy, transmission electron microscopy (TEM), and low temperature
nitrogen gas adsorption measurements. Antimicrobial activity and minimum inhibitory con-
centration of a leaf extract of Bambuseae arundinacea was tested against the bacteria
Escherichia Coli (E. Coli) and Staphylococcus aureus (S. Aureus), along with the fungus
Candida albicans (C. Albicans). A S. aureus active ethanolic leaf extract was loaded into
the above Tabasheer-derived porous silicon. Initial studies indicate sustained in vitro anti-
bacterial activity of the extract-loaded plant derived pSi (25 wt %, TGA), as measured by
disk diffusion inhibitory zone assays. Subsequent chromatographic separation of this
extract revealed that the active antimicrobial species present include stigmasterol and 2,6-
dimethoxy-p-benzoquinone.
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Introduction
The rise in drug-resistant pathogens is of major importance and rightly receiving significant
worldwide attention [1]. A multitude of alternatives to antibiotics are being explored, including
the use of specificmetallic ions, biomolecules and even predatory pathogens themselves like
phages [2]. There is also increasing interest in adaptable biomimetic strategies to combat
multi-drug resistant (MDR) strains of bacteria. Of these, plant-derived approaches are particu-
larly promising for supplying indigenous low-cost therapies [3]. They are also highly amenable
to synergistic approaches where a multitude of antimicrobial weapons are employed [4]. Whilst
phytochemistry is an established field, and increasing research is now being undertaken on
their utility with regard antibiotic-resistant microorganisms [5–7], we are not aware of prior
studies combining biodegradable biomaterial and antimicrobial extraction from a single type
of plant.
We chose bamboo as our prototype example here, because this plant is highly abundant,
rapidly growing, can excrete a form of relatively pure mesoporous silica from its stems [8] and
some preliminary studies claim its leaf extracts may exhibit significant activity against MDR
bacteria [9–10]. The use of nanostructuredmesoporous biomaterials to deliver plant antimi-
crobial extracts is also very well alignedwith synergistic approaches, since these types of bioma-
terials, such as “black silicon”, have been shown to have mechano-responsive bactericidal
activity via their surface topography [11] and can provide loading with antibacterial-active
metal ions such as silver [12] and sustained release of antimicrobial peptides & enzymes.
In order to achieve sustained delivery from a biodegradable silicon-based carrier, for this
study we selectedmesoporous silicon (pSi). Porous silicon, with its nanoscale architecture and
tunable surface chemistry, is a promising resorbable nontoxic biomaterial for a broad variety of
applications: in vivo biosensors [13], and tissue engineering [14], and carrier for controlled
drug delivery [15–17]. The most conventional methods for preparing biodegradablemesopor-
ous silicon particles are anodization of single crystal silicon wafers [18] and metal-assisted
stain etching processes [19]. Rather than employing these methods—that use corrosive
reagents (hydrofluoric acid, HF) and expensive Si feed stocks—we select the eco-friendly alter-
native of producing pSi from silicon accumulator plants/agriculture waste [20]. Multiple land-
based plants typically absorb bio-available silicon in the form of organic silicates such as mono-
silicic or orthosilicic acid [21]. Among well-known silicon accumulator plant (Tabasheer) have
a relatively high percentage of organic silica (95%) [8] compared to other silicon accumulator
plants which typically contain about 25–30% silica [22].
Apart from being an excellent source of silica, another important feature of Bambuseae is
that it has beenwidely reported that the leaves, root, bark and other constituent parts possess
therapeutic activities used to alleviate some medical ailments because of its phytomedical con-
stituents. In particular, pharmacological studies on different parts of Bambuseae arundinacea
shows that this plant possesses a variety of biological activities including antibacterial activity
[23–25]. It should also be emphasized that the Tabasheer component of Bambuseae alone has
an extensive history of medicinal use, primarily in herbal treatments as an antipyretic, antispas-
modic, and antiparalytic [26].
Thus using Bamboo as a source of silica as well as ideally a variety of bioactive components,
our aim is to develop an eco-friendly drug deliverymatrix where the carrier (pSi) is derived
from the stem and drug (antibacterial agents in this case) is gleaned from the leaf of the same
plant. This goal is accomplished by fabricating pSi from Tabasheer powder obtained from the
nodal joints of the bamboo tree and loaded with an antibacterial extract originating from leaves
of the same type of plant. The fabrication process, extraction of antibacterial agents from the
leaf and subsequent loading of antibacterial extracts into plant-derived pSi, evaluation of
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sustained release of antibacterials from the drug carrier, and identification process of some of
the compounds responsible for antibacterial activity are discussed herein.
Materials and Methods
Fabrication of Plant derived Silicon
In a typical experiment 0.5 g of Tabasheer powder (ground from commercially-available pieces
(Bristol Botanicals Ltd.) using a ball mill) was suspended in 20 mL 10% hydrochloric acid. The
solution was stirred constantly at 100°C for 2 hrs by replenishing hydrochloric acid for every
30 min. After 2 hrs of heating the powder was washed with D.I water, filtered, and vacuum
dried overnight. The dryHCl washed powder was loaded in a quartz boat (1.5 x10 cm) and cal-
cinated at 500°C in presence of O2 for 2 hrs in a tube furnace. The calcinated powder was then
added to magnesium powder in the molar ratio of 1:2 (SiO2: Mg). Sodium chloride was added
to the above reaction blend in the ratio of 1:1 by weight. Then this mixture was reduced at
600°C for 2 hrs in presence of Argon in a tube furnace. After reduction the residual magnesium
phases were removed by heating the reduced sample with 36% HCl at 70°C for 1 hr.
Extraction of antibacterials from Bambuseae arundinacea leaves
Fresh leaves of the plant Bambuseae arundinacea were collected in June 2013 from Eluru,
Andhra Pradesh, India, under the supervision of one of the authors (JK) on the private prop-
erty of Mr. Veerakumar Chintapalli, with his permission. This is a plant common to the region
that does not fall into a category of endangered or protected species (according to the Interna-
tional Union for the Conservationof Nature (IUNC). These leaves were subsequently exam-
ined by Barney L. Lipscomb, systematic botanist from Botanical Research Institute of Texas,
Fort Worth, TX, USA. The plant leaves were shade dried for two days and coarsely powdered
(10 g) and extractedwith ethanol (100 mL) at a temperature of 85°C in a Soxlet extractor. After
3 hrs of extraction, extract was concentrated through use of a rotary vacuum evaporator and
the dry extract (0.5 g) was stored at -4°C.
Loading of ethanolic leaf extract into tabasheer derived pSi
Small amounts of pSi derived from Tabasheer (typically ~10 mg), fabricated according to the
above process, were soaked in 0.120 g of extract dissolved in 1 mL of ethanol for 2 hrs. Then
this mixture was heated at 70°C for 30 min. The above mixture was centrifuged; supernatant
was removed, and washed with sterile water twice and dried under vacuum overnight.
Disc diffusion assay
Antibacterial activity of the extract and extract loaded in pSi was tested using a disc diffusion
assay. Dry plant extract (1.3 mg) was dissolved in 10% DMSO and 60 μL of extract was placed
aseptically on a sterile filter paper disc (diameter 6 mm) and transferred to an inoculated
Luria-Bertani (LB) agar plate seededwith the bacterial culture (107 CFU/ml, 24 hrs). Discs
injectedwith 60 μL of 10% DMSO were used as a negative control. Then the plates were incu-
bated at 37°C for 18 hrs. After the allotted period, the inhibition zones formed were measured.
All the samples were run in triplicate. pSi powder (20 mg) loaded with ethanol leaf extract was
tested for the evaluation of sustained antibacterial activity of the leaf extract loaded pSi. pSi
powder (20 mg) was suspended in 0.6 mL of sterile DI water in a 10 mL vial. The vial was con-
tinuously rotated using an agitating apparatus at 37°C. After 24 hrs of agitation the vial was
centrifuged and the supernatant was drawn carefully into a sterile vial. This procedure was
repeated after replenishing 0.6 mL sterile DI water into the vial. Discs injectedwith 60 μL of
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sterile DI water were used as a negative control. A 60 μL fraction of the supernatant was
injected onto paper discs (triplicate) and transferred to an agar plate seededwith bacterial cul-
ture (107 CFU/ml, 24 hrs) and incubated at 37°C for 18 hrs to measure inhibition zones.
Micro broth dilution assay
An ethanol leaf extract (5.2 mg/mL), derived as described above, and was dissolved in dissolved
in 10% DMSO. Dilutions of crude extract were prepared in Luria-Bertani (LB) broth by adding
50 μL of Luria-Bertani (LB) broth to 50 μL of extract. The extract solutions were then serially
diluted (1:1) down to give 2.6, 1.3, 0.65, 0.325, 0.1625 mg/mL concentrations of crude extract.
Bacteria at a concentration of 107 CFU/ml were added and after 18 hrs of incubation the optical
densities of the samples were measured at 600 nm. Sterile water added to Luria-Bertani (LB)
broth was used as a negative control. For this extract, a MIC value of 1.3 mg/mL was obtained.
Results and Discussion
The individual steps of fabrication route are summarized in Fig 1. Commercially-available
pieces of Tabasheer (Concretio silicea bambuseae from Bristol Botanicals Ltd.) were first
ground to a fine powder using a commercial ball mill. An initial washing process of the Tabash-
eer powder with dilute hydrochloric acid (10%) allowed the removal of metallic residues possi-
bly deposited during the plant grinding process. This dried powder was then calcinated in the
presence of oxygen to extract biogenic silica from the purifiedTabasheer powder. The extracted
silica was subsequently converted to pSi by magnesiothermic reduction using magnesium
powder in a molar ratio of 1:2 (SiO2: Mg). [20] The highly exothermic nature of this reaction
between silica and magnesiumwas controlled by adding sodium chloride as a thermal modera-
tor, as well as to maintain porosity. Washing the product of this reaction with 36% hydrochlo-
ric acid dissolves all the traces of magnesiumwhich was confirmed by energy dispersive X-ray
analysis (EDX) (S1 Fig). This magnesiothermic reduction resulted in the formation of pSi
microparticles comprised of an aggregate of small nanoparticles creating nanopores along the
microparticle surface, as gauged by transmission electronmicroscopy (Fig 2a). High resolution
TEM analysis (Fig 2b) reveals the presence of numerous small Si nanocrystals embedded in an
amorphous matrix; lattice imaging provides evidence for the cubic phase structure of these
nanocrystals,with the<111> lattice spacing of 0.310 nm readily visualized. Electron diffrac-
tion patterns (inset Fig 2b) further support the characterization of the pSi derived from the
magnesium-reduced calcinated Tabasheer as polycrystalline in nature.
In a manner complementary to TEM, analysis of a typical reaction product by field emission
scanning electronmicroscopy (FESEM) reveals a microparticlemorphologywith a wide distri-
bution of sizes (mean diameter of 24±20 μm) and uniformly distributed pores with a mean
size of 32 nm (± 8 nm) on the siliconmicroparticle surface (Fig 3b). Consistent with FFT dif-
fraction analysis, XRD patterns associated with this type of magnesium-reduced calcinated
Tabasheer sample shows peaks at 2θ = 28°, 47°, and 56°, ascribed to crystalline silicon reflec-
tions associated with the (111), (220), and (311) indices, respectively (S2 Fig). Raman spectro-
scopic measurements indicate the characteristic crystalline Si phonon at 521 cm-1 (S3 Fig). The
presence of a v(Si-O-Si) stretching vibration at 1087 cm-1 (FT IR, S4 Fig) is consistent with sig-
nificant oxide content in the matrix.
This pSi produced by the magnesium-reduction of calcinated Tabasheer has a surface area
of 178 m2/g, a pore volume of 0.506 ml/g, and an average pore diameter of 11 nm according to
the nitrogen gas adsorption data (S5 Fig). Such values were derived from nitrogen gas adsorp-
tion/desorption data, with computational analysis of the isotherms based on the BET (Bru-
nauer-Emmett-Teller) and / or BJH (Barret-Joyner-Halenda) methods, underpinned by the
Single Plant Derived Nanotechnology
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classical Kelvin equation, which facilitated the calculation of surface area, pore volume (from
the adsorption isotherm), average pore size and pore size distribution.
The phytochemicals associated with possible antibacterial activity were extracted from dried
leaves of the plant Bambuseae arundinacea. Shade-dried powdered leaves were subjected to a
Fig 1. Eco-friendly fabrication route for extraction of pSi from tabasheer. Optical image of grounded tabasheer powder obtained from Bamboo, b)
calcination of 10% HCl washed tabasheer in a tube furnace, c) magnesiothermic reaction of calcinated tabasheer powder, and pure pSi powder obtained
after washing with 36% HCl.
doi:10.1371/journal.pone.0163270.g001
Fig 2. TEM images of plant derived pSi. a) low magnification image of free standing pSi microparticle, b) high
resolution TEM image with a small silicon crystalline domains in the range of 4–8 nm, inset shows polycrystalline
orientation of silicon nanocrystallites (scale bar of a) = 100 nm; b) = 2 nm).
doi:10.1371/journal.pone.0163270.g002
Single Plant Derived Nanotechnology
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continuous hot extractionwith ethanol (95%) in a Soxhlet extractor, followed by concentrating
the extract under vacuum. The dried extract dissolved in dimethyl sulphoxide (10%) showed
activity (evaluated by disc diffusion and microbroth dilution assays) against gram positive bac-
teria Staphylococcus aureus (ATCC 25923) in contrast to the two other tested species—gram
negative Escherichia coli (ATCC 25922), and fungal strain Candida albicans (ATCC 10231);
this extract showed no measureable activity versus the latter two species. The detailed process
of extraction and antibacterial assays are described in the methods section.
The leaf derived antibacterial extract was then loaded into the pSi by a wet loadingmethod
to give a 25% loading capacity (by weight) as analyzed by thermo-gravimetric analysis (TGA)
(Fig 4). Exposure of the extract and the extract-loaded into the plant-derived pSi showed mea-
surable antibacterial activity versus S. aureus. The measured inhibition zones of the extract and
extract-loadedpSi (in dry powder form) are listed in Table 1. Comparable levels of antibacterial
activity are noted. The sustained release of active species loaded into the pSi were also moni-
tored for a period of time until any measureable antibacterial activity ceased against S. aureus
using agar plate diffusion assay (Fig 5). Significant antibacterial activity was observed for a
period up to 16 days. It should be also emphasized that no measureable antibacterial activity
versus S. aureus has been observed for this pSi component alone (as a control).
To begin the separation and identification process of the active phytochemicals responsible,
the dried leaf extract obtained from Bambuseae arundinacea was initially fractionatedwith
four following solvents based on their polarity ranging from low to high: petroleum ether
(3x10 mL), chloroform (CHCl3, 3x10 mL), ethyl acetate (EtOAc, 3x10 mL) and methanol
(MeOH, 3x10 mL). The fractions of each solvent were then combined and dried under vacuum.
Each dried fractionwas tested for antibacterial activity by plate diffusion assay. Among the
four solvent fractions, the petroleum ether CHCl3, and EtOAc fractions showed activity
against S. aureus (S1 Table). The highly and equally active CHCl3 and EtOAc fractions were
Fig 3. FESEM images and observed pSi microparticle surface morphology. (a) free standing pSi microparticle from magnesium reduced
tabasheer, reaction final product, (b) individual nanopores along the pSi particle surface (scale bar of (a) = 1 μm, (b) = 100 nm.
doi:10.1371/journal.pone.0163270.g003
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then further analyzed to find out the antibacterial agents present. All the four fractions were
monitored with thin layer chromatography (TLC) and similar fractions with the same (Rf and
colour) were combined. The dried combined fractions of CHCl3 and EtOAc were subjected to
preparative TLC using petroleum ether and chloroform (2:3) as a solvent system, which yielded
in five sub fractions. Among these five sub fractions, two sub fractions fraction 5, fraction 8,
were active against S. aureus with inhibition zones of 21 mm, and 22 mm and fraction 9 with
an inhibition zone of 11 mm. Fraction 5 and fraction 8 were further purified by preparative
TLC using the solvent systems chloroform: ethyl acetate: acetic acid (4.5:4.5:1) and hexane:
ethyl acetate (3:2) respectively. The elution of sub fraction 5 yielded fraction 10 and pure com-
pound 1 and sub fraction 8 to afford fraction 11 and compound 2. Compound 1 was further
purified by washing with dichloromethane and methanol. The isolation process, along with
the amounts of fractions obtained after each purification step, is listed in supplementary
information (S6 and S7 Figs). The compound 1 (yellow powder, ~1 mg) was identified as
Fig 4. Thermo gravimetric analysis (TGA) of the extract loaded into pSi. Weight loss curve (in red), heating curve (in blue) of
crude leaf extract loaded pSi (10 mg) was hated in N2 at a ramp rate of 10˚C/ min to a temperature of 400˚C beyond this no further
degradation was observed.
doi:10.1371/journal.pone.0163270.g004
Table 1. Antibacterial activity (against S. aureus) of bamboo extract and extract-loaded pSi after 24 h
incubation period (at 37˚C).
Material Tested Inhibition Zone (mm)
Bamboo leaf extract (78 mg) 18
Extract loaded Tabasheer-derived pSi (2.5 mg of pSI with 25% loading) 13
doi:10.1371/journal.pone.0163270.t001
Single Plant Derived Nanotechnology
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2,6-dimethoxycyclohexa-2,5-diene-1,4-dione (2,6 dimethoxy-p-benzoquinone) based on a
straightforward assignment of combined spectral data (1H NMR, 13C NMR, and ESI-MS) and
compound 2 (white powder, ~2 mg) identified as 3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-
5-ethyl-6 methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17dodecahydro-
1H-cyclopentaphenanthren-3-ol (stigmasterol) by comparing its combined spectral data (1H
NMR, 13C NMR, and ESI-MS) to that reported in the literature [27]. Compound 1, and com-
pound 2 show activity against S. aureus with individual minimum inhibitory concentrations
(MIC) of 35 μg/mL, and 30 μg/mL respectively. The recorded 1H NMR, 13C NMR, and HRMS
spectra for isolated 2, 6 dimethoxy- p-benzoquinone (S8, S9 and S10 Figs), and stigmasterol
(S11, S12 and S13 Figs) are listed in supporting information. Both pure compounds have dem-
onstrated antibacterial activity previously [27–29].
The eco-friendly fabrication route describedhere to extract silicon from Tabasheer resulted
in high yields of nanocrystalline silicon/siliconoxide (~70%) with more than ~99% purity (by
EDX). This fabrication method is relatively economical and eco-friendly, requiring no special-
ized equipment or reagents. Use of a thermal moderator (NaCl) also serving as templating
agent permits retention of nanoscale features (pore morphology) of the pSi during reduction
with magnesium at the modest temperature of 600°C. The pSi formed during this process is
highly crystalline, as strongly confirmed by HRTEM lattice imaging, x-ray diffraction (XRD),
and Raman spectroscopy. Taken in concert, and recognizing that both FT IR and EDX analyses
Fig 5. Antibacterial activity of the extract loaded Tabasheer-derived pSi carrier against S. aureus. Using a disk diffusion assay, the
release of antibacterials and associated activity was monitored until the activity ceased.
doi:10.1371/journal.pone.0163270.g005
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show significant oxygen content in the matrix, one can view the porous microstructure of this
material as series of Si nanocrystals embedded in an amorphous oxide phase. In terms of poros-
ity, analysis of low temperature nitrogen adsorption data in a BET isotherm-typemodel reveal
pore size values in the mesoporous range, with associated surface areas also consistent with this
classification.
Antibacterial assays on the leaf extract obtained from Bambuseae arundinacea show prom-
ising activity against S. aureus. Incorporation of the antibacterial leaf extract into the pSi ren-
dered us to study the controlled release of the antibacterial agents from the drug carriermatrix.
The wet loadingmethod used to load the extract into pSi allows slow diffusion of the phyto-
chemicals into the pores to yield a 25 wt% loading. TGA analysis shows an initial weight loss
(<5%) from ambient temperatures to 100°C that is likely due to the volatile components and
desorption of physically adsorbedwater, with the weight loss from 150 to 400°C assumed to be
associated with degradation of bioactive phytochemicals identified during the extraction/sepa-
ration process.
A steady plateau of inhibition zones (measured at 24h intervals) over the initial 7d window,
followed by a gradual diminution in antibacterial activity over the next 9 days, reflects a sus-
tained release of active species in vitro. While the duration of the release window for the active
therapeutics in this case does not currently extend to the maximum length of that of selected
known antibacterial drug delivery systems based on anodized pSi, [30] it does nevertheless
demonstrate utility for this system in a possible clinical context. The key fact that relatively
straightforward experimental conditions- available globally—are needed to simultaneously
provide both drug and nanoscale drug carrier is an encouraging point to stimulate further
practical development.
Conclusions
In summary, this work clearly demonstrates that a single plant type can yield useful therapeu-
tics that are delivered from a drug delivery carrier derived from a silicon accumulator plant.
This eco-friendly fabrication route is an ideal alternative to conventional etching methods for
preparing oxidized pSi powders of high purity in competitive yields, possessing high surface
areas as well. The above approach thereby provides multiple appealing advantages on different
levels—with a primary focus on the economy and simplicity in fabrication of nanoscale carriers
capable of sustained release, along with incorporation of concomitantly-present active thera-
peutics. Future work will focus on (i) scalability of the above process, (ii) modification of the
pSi scaffold for tunability of degradation to affect drug release, and (iii) an expansion of the
range of active therapeutics for incorporation and release from this type of plant-derived nano-
structured porous carrier (including other related natural product-derived species). It is per-
ceived that the dual advantage of the single plant source for creating this type of drug delivery
carriermatrix would be an ideal low-cost option for countries with extensive resources of sili-
con accumulator plants in future synergistic drug delivery applications.
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